Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver
- PMID: 11112788
- DOI: 10.1074/jbc.M010029200
Glucose and insulin function through two distinct transcription factors to stimulate expression of lipogenic enzyme genes in liver
Abstract
Transcription of a number of genes involved in lipogenesis is stimulated by dietary carbohydrate in the mammalian liver. Both insulin and increased glucose metabolism have been proposed to be initiating signals for this process, but the pathways by which these effectors act to alter transcription have not been resolved. We have previously defined by electrophoretic mobility shift assay a factor in nuclear extracts from rat liver, designated the carbohydrate-responsive factor (Cho- RF), that binds to liver-type pyruvate kinase and S(14) promoters at sites critical for regulation by carbohydrate. The sterol regulatory element binding protein-1c (SREBP-1c) has also emerged as a major transcription factor involved in this nutritional response. In this study, we examined the relationship between SREBP-1c and ChoRF in lipogenic gene induction. The two factors were found to possess distinct DNA binding specificities both in vitro and in hepatocytes. Reporter constructs containing binding sites for ChoRF were responsive to glucose but not directly to insulin. On the other hand, reporter constructs with an SREBP-1c site responded directly to insulin. The S(14) gene possesses binding sites for both ChoRF and SREBP, and both sites were found to be functionally important for the response of this promoter to glucose and insulin in hepatocytes. Consequently, we propose that SREBP-1c and ChoRF are independent transcription factors that mediate signals generated by insulin and glucose, respectively. For many lipogenic enzyme genes, these two factors may provide an integrated signaling system to support the overall nutritional response to dietary carbohydrate.
Similar articles
-
The role of SREBP-1c in nutritional regulation of lipogenic enzyme gene expression.J Biol Chem. 2002 Jul 26;277(30):27029-35. doi: 10.1074/jbc.M202638200. Epub 2002 May 16. J Biol Chem. 2002. PMID: 12016216
-
Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.J Biol Chem. 2004 May 7;279(19):20314-26. doi: 10.1074/jbc.M312475200. Epub 2004 Feb 25. J Biol Chem. 2004. PMID: 14985368
-
SREBP-1c mediates the insulin-dependent hepatic glucokinase expression.J Biol Chem. 2004 Jul 16;279(29):30823-9. doi: 10.1074/jbc.M313223200. Epub 2004 Apr 30. J Biol Chem. 2004. PMID: 15123649
-
Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver.Biochimie. 2005 Jan;87(1):81-6. doi: 10.1016/j.biochi.2004.11.008. Biochimie. 2005. PMID: 15733741 Review.
-
New perspectives in the regulation of hepatic glycolytic and lipogenic genes by insulin and glucose: a role for the transcription factor sterol regulatory element binding protein-1c.Biochem J. 2002 Sep 1;366(Pt 2):377-91. doi: 10.1042/BJ20020430. Biochem J. 2002. PMID: 12061893 Free PMC article. Review.
Cited by
-
Glucose activates ChREBP by increasing its rate of nuclear entry and relieving repression of its transcriptional activity.J Biol Chem. 2008 Aug 29;283(35):24029-38. doi: 10.1074/jbc.M801539200. Epub 2008 Jun 30. J Biol Chem. 2008. PMID: 18591247 Free PMC article.
-
Correlation between ratio of fasting blood glucose to high density lipoprotein cholesterol in serum and non-alcoholic fatty liver disease in American adults: a population based analysis.Front Med (Lausanne). 2024 Sep 4;11:1428593. doi: 10.3389/fmed.2024.1428593. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39296907 Free PMC article.
-
Akt2 is required for hepatic lipid accumulation in models of insulin resistance.Cell Metab. 2009 Nov;10(5):405-18. doi: 10.1016/j.cmet.2009.10.004. Cell Metab. 2009. PMID: 19883618 Free PMC article.
-
Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease.J Clin Invest. 2020 Mar 2;130(3):1453-1460. doi: 10.1172/JCI134165. J Clin Invest. 2020. PMID: 31805015 Free PMC article. Clinical Trial.
-
Homeostasis of Glucose and Lipid in Non-Alcoholic Fatty Liver Disease.Int J Mol Sci. 2019 Jan 13;20(2):298. doi: 10.3390/ijms20020298. Int J Mol Sci. 2019. PMID: 30642126 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical